T he article by Mazzone and colleagues' in this issue of Circulation provides highly objective evidence suggesting the association of an acute inflammatory reaction with "unstable angina." Although several studies cited in the report have previously suggested an inflammatory component to this syndrome, the present study is distinctive in that rather than relying on the appearance of or depletion of inflammatory mediators, the current study demonstrates a transcardiac increase in the surface expression of CD11b/CD18 in coronary sinus monocytes and granulocytes when compared with simultaneous control samples drawn from the aortic blood. Although there appears to be considerable intersubject variation in the degree of activation, the results are unequivocal and very impressive.
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The data in this article suggest an inflammatory reaction that does not appear to be related to a primary myocardial cell injury as defined by elevation of serum enzymes. Interestingly, activation of CD11b/CD18 in aortic leukocytes is not elevated by this syndrome despite the very striking (threefold) increase in the leukocytes in coronary sinus blood. Because coronary sinus blood represents roughly 5% of the blood flow, one would ordinarily expect that increases would soon be seen in surface CD11b/CD18 expression on circulating neutrophils. Because there is no evidence in the area of leukocyte biology for downregulation of CD11b/ CD18 after its upregulation, one is forced to consider possibilities by which the neutrophils activated in the coronary circulation do not appear in the systemic circulation.
As with any truly original article, the questions asked by this study are potentially as exciting as the findings presented. Obviously, the most pertinent question to be addressed is the origin of this inflammatory response and its role in the course of unstable angina. From data gained in experimental models, there are several different potential sources of an inflammatory reaction attendant to acute coronary syndromes with distinctive mechanisms, consequences, and therapeutic approaches. This communication attempts to examine the relevance of the experimental data to these clinical observations and the role of cardiovascular inflammation in the setting of coronary artery disease.
Induction of Inflammation in Coronary
Artery Disease In coronary artery disease, there are two important potential sites at which neutrophils may be activated and potentially induce an inflammatory injury. The two potential sites of neutrophil activation are the atherosclerotic obstruction site in the coronary vessel and the microcirculatory interface with injured myocardium. It is likely that both of these sites are pertinent in the acute coronary syndrome but have very different pathophysiological mechanisms and implications. One of the important messages of this article relates to the potential for observing one of these mechanisms in the absence of the other. This article is a potent demonstration from clinical data of the importance of studying these two mechanisms separately and the possibility of approaching them therapeutically with different strategies toward entirely different therapeutic end points.
Activation of Leukocytes at the Site of Coronary Obstruction
A variety of experimental studies have suggested that neutrophil-induced endothelial dysfunction occurred near the site of coronary obstruction2 and that neutrophils may actually adhere to and, to some degree, transmigrate across the endothelial wall. The mechanism by which the neutrophil undergoes activation at this site has not yet been completely clarified, but a number of interesting possibilities exist. Until integrin activation occurs, neutrophil adhesion to endothelial cells by CD11b/CD18-ICAM-1 adhesion mechanisms is very sensitive to shear stress as low as 0.5 dyne/cm2, whereas arterial shear stress is more than 25-fold higher. 3 Obviously, distal to an obstruction there is considerable turbulence so that there is a strong likelihood of a low shear stress zone immediately distal to the obstruction. In addition, in unstable angina syndromes, it is now well known that thrombotic turnover is constantly occurring so that thrombin levels are likely to be quite high. Thrombin is a potent inducing ligand for effecting increased P-selectin on the surface of endothelial cells.4 P-selectin is an adhesion molecule found on the surface of activated platelets and endothelial cells.4 In the latter, the P-selectin is ordinarily stored in Weibel Palade bodies, and in the former, it is stored in platelet granules. P-selectin is rapidly shifted to the cell surface in response to thrombin and is retained there for 30 minutes to 1 hour,4 during which time it can sustain neutrophil adhesion and effect neutrophil mar-gination that is resistant to considerable shear stress in a complex ligand adhesion mechanism that also requires the presence of L-selectin on the neutrophils.5,6 Similarly, platelet aggregation occurs at this site, and neutrophil-platelet adhesion can occur by a P-selectin interaction with a yet-undefined ligand on the neutrophil. This potential interaction among platelets, leukocytes, and endothelial cells is a fertile ground for upregulation of CD11b/CD18. Perhaps most directly, thrombin stimulates the enzymatic pathway leading to the formation of platelet activating factor (PAF), which is a potent chemotactic agent that, in addition to platelet activation, increases surface expression and activation of CD11b/CD18 and promotes neutrophil adhesion to endothelial cells as well as homotypic aggregation of neutrophils.7 Neutrophils thus stimulated excrete a variety of other potential neutrophil activators, such as leukotrienes, interleukin-8, and, potentially, reactive oxygen itself. Adherent platelets contain surface cytokines, such as interleukin-1, which induce endothelial ICAM-1 and interleukin-8 production.
Evidence suggests that functional endothelial abnormalities may occur as a result of neutrophil interaction with the endothelium of large coronary arteries in ischemic heart disease models.2 Nevertheless, although some infiltration of neutrophils are seen, the number is relatively small, and one presupposes that most of the activated neutrophils are released to move downstream. If these are indeed the activated neutrophils that are analogous to those measured in the current study, the questions remain as to (1) how are they released, (2) why are they not sequestered in the cardiac microcirculation, and (3) where are they sequestered after traversing the coronary sinus so that they are not seen in the arterial circulation?
It is likely that neutrophils escape from adhesion complexes induced in this turbulent circulation because of hemodynamic variability, shifting shear stress condition, alterations in levels of generated thrombin, and the intrinsic instability of P-selectin that remains upregulated for only 30 minutes to 1 hour. Thus, in a phasic syndrome such as unstable angina, it is easy to imagine that the high-pressure flow (shear stress) system could ultimately project the neutrophils downstream out of the postobstructive chamber. The experimental model of chronic cyclic reduction of coronary blood flow is associated with intermittent release of blood cell aggregates, resulting in reinstitution of higher coronary flow, and may be a laboratory model of a process similar to unstable angina. 8 However, because the neutrophils have been highly activated, they have, in all likelihood, lost some of the L-selectin from their surface. L-selectin is closely related to P-selectin and is essential to the margination of neutrophils in high shear stress, which is necessary for transmigration even across the microcirculation (where shear stresses are above 2.5 dyne/cm2). L-selectin on the surface of the neutrophil has been demonstrated to be critical for leukocyte rolling and margination.6 Data suggest that either P-selectin or E-selectin are also necessary for optimal margination,5,6 and the leukocyte and endothelial selectins may actually interact.6 Activation of adherent neutrophils increases the affinity of the CD11b/CD18 complex for endothelial ICAM-1 and also induces the proteolytic shedding of the L-selectin.9 It has been postulated that this allows the new, highaffinity CD11b/CD18-ICAM-1 complex to mediate neutrophil transmigration. However, the early loss of L-selectin, which may occur as a consequence of upstream activation, may markedly reduce the possibility of margination and transmigration of neutrophils regardless of their state of CD11b/CD18 activation.9
In addition, because no tissue injury has occurred adjacent to the microcirculation, the complement-derived leukotactic gradient generated by tissue injury would be expected to be absent. Although some trapping in the microvessels might occur as a result of changes in leukocyte shape or homotypic aggregation, it would not be a surprise to find the largest component of activated leukocytes egressing via the coronary sinus blood as observed in the present study.1 However, because of its unusual microcirculation and relatively low shear stress (pulmonary artery pressures are much lower), activated leukocytes may well be trapped in the pulmonary circulation and thus disappear from the systemic circulation. Similarly, homotypic aggregates and activated leukocytes may be trapped in the spleen, which is heavily involved in removal of activated leukocytes.
Although theoretical, this construct represents a very feasible explanation for the data presented and has important pathophysiological significance. In the first place, it is possible that neutrophils and monocytes may injure the coronary vessel distal to an obstruction in a way that promotes thrombosis or vascular injury or impairs endothelium-derived relaxation, as previously described in experimental models. In the second place, it is possible that there is considerable trapping of activated neutrophils in the microcirculation of the lung. People with acute coronary syndromes frequently are seen to have some mild desaturation requiring treatment with supplemental oxygen, and a low-level pulmonary inflammation may exist.
Neutrophil Activation at the Microcirculatory Interface With Injured Myocardium
The association of inflammation and inflammatory cells with myocardial infarction has been described for many years in both clinical studies and experimental models of myocardial infarction.10 Although this inflammatory infiltration was classically described as occurring from 12 hours to 5 days after the initial event, it is now clear that reperfusion (or partial perfusion from collateral vessels) markedly accelerates the inflammatory reaction within the first hour.11 Substantial evidence suggests that this acute reaction to injury following closely on reperfusion may actually extend injury in jeopardized areas of the myocardium, and strategies to interdict this consequence have been evaluated in a variety of experimental models.10'11 Early experience with anti-inflammatory agents in myocardial infarction models was so promising that a clinical trial of high-dose glucocorticoid therapy was initiated, which resulted in catastrophic consequences. 12 It is now appreciated that although the inflammatory reaction associated with myocardial tissue necrosis may involve an acute inflammatory phase (when reperfusion is instituted), it is also critical to the healing-and-remodeling phase of myocardial infarction. Although mechanisms controlling the former have been extensively studied and characterized so that there is reasonable consensus regarding factors Circulation Vol 88, No 2 August 1993 that control the acute inflammatory response, the more chronic healing phase and its relationship to inflammatory cells have not been extensively characterized. It seems important, however, to review the mechanisms by which neutrophil localization in the microcirculation and transmigration into the tissues occur; while it is not pertinent to the data in the current article (in which tissue injury is absent or minimal), the contrast in mechanisms is important with respect to the strategies one might use to alter the disease process.
It is now generally accepted that the acute inflammatory reaction occurs only in the presence of significant myocardial injury and necrosis and therefore represents a reaction to the initial ischemia/reperfusion injury. Work from our laboratory has suggested that macromolecules released from the ischemic myocardium (inner membrane of the mitochondria) bind Clq and initiate the classic complement pathway.'0 Thus, a complement gradient is initiated between the microcirculation and the tissue that tends to attract leukocyte migration. The complement gradient is dissipated over the first 4 hours of reperfusion in experimental models, and substantial evidence suggests that the maximum neutrophil influx occurs during those hours of reperfusion.13 Activated neutrophils, endothelial cells, and macrophages all are capable of synthesizing other inflammatory mediators, such as PAF, leukotrienes, and interleukin-8, as well as the cytokines known to induce adhesion molecule expression, such as interleukin-1, TNF-a, and interleukin-6. Thus, tissue injury initiates the inflammatory cascade that results in neutrophil margination, activation, and transmigration into extravascular space. This microvascular leukotactic reaction is not dissimilar from the classic inflammatory reactions seen in response to many other stimuli. The reaction begins with initial margination and microvascular sequestration of leukocytes followed by transmigrations into the tissue following the leukotactic gradient emanating from reactions associated with tissue injury or an injurious agent (eg, bacteria). The presence of activated neutrophils in the extracellular space associating with cytokine-stimulated cardiac myocytes (which express ICAM-1) may result in a portion of the injury extension associated with reperfusion.14 Role of Acute Inflammation in Clinical Coronary Disease Although we have endeavored to separate out two distinct mechanisms in which acute inflammation might change the course of coronary artery disease, it is obvious that both of these mechanisms may be found to coexist. Indeed, most models of experimental myocardial infarction involve traumatic occlusion of the coronary vessel initiating ischemic and reperfusion injury. It is no surprise, therefore, that abnormalities of coronary vessel function are frequently described in models of ischemia and reperfusion injury and that the large vessel dysfunction, microvascular dysfunction, and tissue injury components are frequently considered together.
The likelihood is, however, that the macrovascular injury occurs via a localized reaction to the vessel injury and the downstream microvascular dysfunction and tissue injury occur as a result of neutrophil sequestration and transmigration across the endothelium into the extravascular space at the postcapillary level. These distinctions may be clinically important and also emphasize the difference between clinical disease and experimental models. For example, the potential implications of thrombolytic therapy as the initiator of reperfusion in contrast to relieving a ligature in an experimental model may alter the relative importance of several modulators. In the first place, thrombolytic agents are serine proteases that activate complement to some degree in the vascular compartment, resulting in some initial "upstream" preactivation of neutrophils, downregulation of L-selectin, and alterations in the complement-derived gradient in the microcirculation. In addition, an enormous amount of thrombin, cellular aggregates, and inflammatory mediators are likewise released as part of the dissolution of the clot and induce P-selectin surface expression and PAF production. The relative roles of various neutrophil mediators may change considerably as a result. Thus, it is always useful to have data from the clinic to help refine hypotheses developed in the laboratory.
Significance of Inflammation as Part of the Unstable Angina Syndrome The potential significance of an acute inflammatory reaction associated with a partial obstruction of a large coronary vessel can be considered in two general categories: (1) potential role in the acute syndrome and (2) role in vascular injury. Again, these are not mutually incompatible or totally separable but represent the useful construct.
On an acute basis, neutrophils and monocytes present within the postobstructive chamber in an activated state are involved with platelet aggregates and secrete thromboxane A2, leukotriene B4 (leukotriene A4 also from neutrophils is frequently converted to leukotriene C4 or D4 by associated vessels), and activating cytokines. These neutrophils may also infiltrate and injure the vessel wall. Evidence suggests that this acute injury impairs endothelium-derived relaxation, which, coupled with the release of several vasoconstrictive substances cited above, may result in some net vasoconstriction distal to an obstruction. Finally, recent evidence suggests that neutrophils present in a thrombus (bound to platelet P-selectin) potentiates the thrombotic process by increasing fibrin deposition.'5 On a chronic basis, such an injury to the vessel may result in classic changes seen with chronic blood vessel injury, such as subintimal hyperplasia. This type of subintimal thickening has been seen in chronic cyclic reduction of coronary blood flow models over a period of about 1 week, suggesting a general reaction to injury in the vessel distal to a chronic partial occlusion. '6 Obviously, changes in both the endothelium and the subintima will further potentiate or increase the likelihood of vessel narrowing, constriction, and thrombotic processes. Similar dangers attend angioplasty at the atherosclerotic site where the reaction to injury is associated with identical potential complications.
The article by Mazzone and colleagues' suggests that this process is seen only in the patients with unstable angina syndromes. However, the possibility that it occurs in coronary artery disease not presenting with this syndrome cannot be ruled out; the sensitivity of the measurements used and the size of the sample may be inadequate to detect the same ongoing process occur-ring without symptoms. It is noted that 6 of the 14 patients in group 2 (stable angina) demonstrated increases in coronary sinus CDllb/CD18 of 20% or more, whereas only 2 of 10 of group 3 (control) demonstrated such increases. In contrast, only 1 of 14 of the group 2 patients demonstrated a decrease of 20% across the circulation, whereas 4 of 10 of the group 3 patients demonstrated such decreases. The possibility exists, therefore, that the turbulent circulation around the diseased coronary vessel may frequently effect an inflammatory process in the absence of symptoms, and its role in progression of the lesion either acutely or chronically should be recognized as a potential pathophysiological event of clinical significance.
Thus, in addition to the role of acute inflammation in reperfusion injury, it is possible that inflammatory injury is an important part of coronary vascular disease initiated locally at the site of obstruction via a distinct population of inflammatory modulators. The very convincing demonstration of the presence of this acute inflammatory reaction in the absence of myocardial injury emphasizes the fact that it should be considered as a separate and distinct pathophysiological entity. The role of anti-inflammatory intervention treatment of ongoing coronary disease remains to be elucidated.
